Making an immensely shocking revelation, a recent report has claimed that a researcher from the University of Connecticut, who was working on the health-related advantage of a chemical abundantly present in red wine, made up the data as per his benefit in as many as 145 different research projects.

The reports have been confirmed recently after the completion of a probe that was in progress since the last three years.

During the investigation, the officials from the University informed that around 11 scientific journal studies that were co-lead by the guilty party, Dr. Dipak Das, whose work was mainly related on finding whether or not the drug “Resveratrol”, an antioxidant which is mainly found in the skin of grapes, can hold some sort of effectiveness for preventing coronary heart ailments or whether it can prove effective in killing cancer cells.

Resveratrol has been associated with these sorts of advantages in a variety of studies in the recent past. However, it has been claimed that Das has association with the maker of Resveratrol, and therefore he fabricated the data accordingly. However, the drug maker has denied all such comments.

While expressing his opinion in this regard, the Director of the Center for Regenerative Medicine and Skeletal Development, David Rowe said: “If you are blatantly honest about your failures, you will get nowhere. The fact is that reviewing agencies want success. Therefore you spin your data in the most favorable way”.

He further claimed that the true risk comes into play in such cases. The situation then goes entirely soggy and unclear

In this regard, Melissa Healy, the Times health writer has provided an explanation of a study showing obese men who used Resveratrol in more than needed doses resulted in an enhancement in their metabolic functioning along with a decrease in the evidence of inflammation, most probably like they were getting more "athletic" with no excessive or body building workouts.